Blueprint Medicines
BPMC
$108.55
Share price
2.16%
Change (1 day)
98.45%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.91 B
According to Blueprint Medicines 's latest financial reports the company's total liabilities are $0.91 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Blueprint Medicines - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.91 B | 9.99% |
| 2022-12-31 | $0.83 B | 196.72% |
| 2021-12-31 | $0.28 B | 13.36% |
| 2020-12-31 | $0.24 B | 2.04% |
| 2019-12-31 | $0.24 B | 100.91% |
| 2018-12-31 | $0.12 B | 31.98% |
| 2017-12-31 | $91.76 M | 31.63% |
| 2016-12-31 | $69.71 M | 99.65% |
| 2015-12-31 | $34.91 M | 140.89% |
| 2014-12-31 | $14.49 M | 157.43% |
| 2013-12-31 | $5.63 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | $1.04 B | 13.72% | 🇺🇸 USA |
 OPKO Health
OPK | $0.62 B | -32.24% | 🇺🇸 USA |
 Isoray
ISR | $3.26 M | -99.64% | 🇺🇸 USA |